The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells

Andre Brannvoll,Xiaoyu Xue,Youngho Kwon,Smaragdi Kompocholi,Anne Katrine W. Simonsen,Keerthana S. Viswalingam,Leticia Gonzalez,Ian D. Hickson,Vibe H. Oestergaard,Hocine W. Mankouri,Patrick Sung,Michael Lisby
DOI: https://doi.org/10.1016/j.celrep.2020.107849
IF: 8.8
2020-01-01
Cell Reports
Abstract:Replication-blocking DNA lesions are particularly toxic to proliferating cells because they can lead to chromosome mis-segregation if not repaired prior to mitosis. In this study, we report that ZGRF1 null cells accumulate chromosome aberrations following replication perturbation and show sensitivity to two potent replication-blocking anticancer drugs: mitomycin C and camptothecin. Moreover, ZGRF1 null cells are defective in catalyzing DNA damage-induced sister chromatid exchange despite accumulating excessive FANCD2, RAD51, and γ-H2AX foci upon induction of interstrand DNA crosslinks. Consistent with a direct role in promoting recombinational DNA repair, we show that ZGRF1 is a 5′-to-3′ helicase that catalyzes D-loop dissociation and Holliday junction branch migration. Moreover, ZGRF1 physically interacts with RAD51 and stimulates strand exchange catalyzed by RAD51-RAD54. On the basis of these data, we propose that ZGRF1 promotes repair of replication-blocking DNA lesions through stimulation of homologous recombination.
What problem does this paper attempt to address?